DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Vivaglobin (Immune Globulin Subcutaneous Human) - Herpes Simplex Serology Positive - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Herpes Simplex Serology Positive (3)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Vivaglobin (Immune Globulin Subcutaneous Human) where reactions include herpes simplex serology positive. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Vivaglobin side effects in female

Reported by a physician from United States on 2012-06-19

Patient: female, weighing 61.2 kg (134.7 pounds)

Reactions: Herpes Simplex Serology Positive, Transmission of AN Infectious Agent VIA A Medicinal Product

Drug(s) suspected as cause:
Vivaglobin

Vivaglobin

Vivaglobin

Vivaglobin

Vivaglobin

Vivaglobin

Vivaglobin

Vivaglobin
    Dosage: (9.6 g 1x/week, stop day may 2011 subcutaneous)
    Indication: Humoral Immune Defect
    Start date: 2010-06-07

Vivaglobin
    Dosage: (9.6 g 1x/week, stop day may 2011 subcutaneous)
    Indication: Humoral Immune Defect
    Start date: 2011-03-29

Vivaglobin
    Dosage: (9.6 g 1x/week, stop day may 2011 subcutaneous)
    Indication: Humoral Immune Defect
    Start date: 2010-11-22

Vivaglobin
    Dosage: (9.6 g 1x/week, stop day may 2011 subcutaneous)
    Indication: Humoral Immune Defect
    Start date: 2011-01-06

Vivaglobin
    Dosage: (9.6 g 1x/week, stop day may 2011 subcutaneous)
    Indication: Humoral Immune Defect
    Start date: 2011-01-26

Vivaglobin
    Dosage: (9.6 g 1x/week, stop day may 2011 subcutaneous)
    Indication: Humoral Immune Defect
    Start date: 2009-11-17

Vivaglobin
    Dosage: (9.6 g 1x/week, stop day may 2011 subcutaneous)
    Indication: Humoral Immune Defect
    Start date: 2010-08-03

Vivaglobin
    Dosage: (9.6 g 1x/week, stop day may 2011 subcutaneous)
    Indication: Humoral Immune Defect
    Start date: 2010-07-06

Vivaglobin
    Dosage: (9.6 g 1x/week, stop day may 2011 subcutaneous)
    Indication: Humoral Immune Defect
    Start date: 2011-02-22

Vivaglobin
    Dosage: (9.6 g 1x/week, stop day may 2011 subcutaneous)
    Indication: Humoral Immune Defect
    Start date: 2010-01-18

Vivaglobin
    Dosage: (9.6 g 1x/week, stop day may 2011 subcutaneous)
    Indication: Humoral Immune Defect
    Start date: 2010-05-11

Vivaglobin
    Dosage: (9.6 g 1x/week, stop day may 2011 subcutaneous)
    Indication: Humoral Immune Defect
    Start date: 2010-08-31

Vivaglobin
    Dosage: (9.6 g 1x/week, stop day may 2011 subcutaneous)
    Indication: Humoral Immune Defect
    Start date: 2009-11-17

Vivaglobin
    Dosage: (9.6 g 1x/week, stop day may 2011 subcutaneous)
    Indication: Humoral Immune Defect
    Start date: 2010-03-16

Vivaglobin
    Dosage: (9.6 g 1x/week, stop day may 2011 subcutaneous)
    Indication: Humoral Immune Defect
    Start date: 2009-12-15

Vivaglobin
    Dosage: (9.6 g 1x/week, stop day may 2011 subcutaneous)
    Indication: Humoral Immune Defect
    Start date: 2010-02-16

Vivaglobin
    Dosage: (9.6 g 1x/week, stop day may 2011 subcutaneous)
    Indication: Humoral Immune Defect
    Start date: 2010-09-28

Vivaglobin
    Dosage: (9.6 g 1x/week, stop day may 2011 subcutaneous)
    Indication: Humoral Immune Defect
    Start date: 2010-10-26

Vivaglobin
    Dosage: (9.6 g 1x/week, stop day may 2011 subcutaneous)
    Indication: Humoral Immune Defect
    Start date: 2010-12-21

Vivaglobin
    Dosage: (9.6 g 1x/week, stop day may 2011 subcutaneous)
    Indication: Humoral Immune Defect
    Start date: 2011-04-27

Vivaglobin

Vivaglobin

Vivaglobin

Vivaglobin

Vivaglobin

Vivaglobin

Vivaglobin

Vivaglobin

Vivaglobin

Vivaglobin

Vivaglobin

Other drugs received by patient: Vivaglobin



Possible Vivaglobin side effects in female

Reported by a pharmacist from United States on 2012-06-11

Patient: female, weighing 61.2 kg (134.7 pounds)

Reactions: Herpes Simplex Serology Positive, Transmission of AN Infectious Agent VIA A Medicinal Product

Drug(s) suspected as cause:
Vivaglobin

Vivaglobin

Vivaglobin

Vivaglobin

Vivaglobin
    Dosage: 9.6 g 2x/week, stop day may 2011 subcutaneous, (9.6 g 2x/week, stop day may 2011 subcutaneous
    Indication: Hypogammaglobulinaemia
    Start date: 2010-06-07

Vivaglobin
    Dosage: 9.6 g 2x/week, stop day may 2011 subcutaneous, (9.6 g 2x/week, stop day may 2011 subcutaneous
    Indication: Immunodeficiency Common Variable
    Start date: 2010-06-07

Vivaglobin
    Dosage: 9.6 g 2x/week, stop day may 2011 subcutaneous, (9.6 g 2x/week, stop day may 2011 subcutaneous
    Indication: Hypogammaglobulinaemia
    Start date: 2010-01-18

Vivaglobin
    Dosage: 9.6 g 2x/week, stop day may 2011 subcutaneous, (9.6 g 2x/week, stop day may 2011 subcutaneous
    Indication: Immunodeficiency Common Variable
    Start date: 2010-01-18

Vivaglobin
    Dosage: 9.6 g 2x/week, stop day may 2011 subcutaneous, (9.6 g 2x/week, stop day may 2011 subcutaneous
    Indication: Hypogammaglobulinaemia
    Start date: 2010-09-28

Vivaglobin
    Dosage: 9.6 g 2x/week, stop day may 2011 subcutaneous, (9.6 g 2x/week, stop day may 2011 subcutaneous
    Indication: Immunodeficiency Common Variable
    Start date: 2010-09-28

Vivaglobin
    Dosage: 9.6 g 2x/week, stop day may 2011 subcutaneous, (9.6 g 2x/week, stop day may 2011 subcutaneous
    Indication: Hypogammaglobulinaemia
    Start date: 2009-11-17

Vivaglobin
    Dosage: 9.6 g 2x/week, stop day may 2011 subcutaneous, (9.6 g 2x/week, stop day may 2011 subcutaneous
    Indication: Immunodeficiency Common Variable
    Start date: 2009-11-17

Vivaglobin
    Dosage: 9.6 g 2x/week, stop day may 2011 subcutaneous, (9.6 g 2x/week, stop day may 2011 subcutaneous
    Indication: Hypogammaglobulinaemia
    Start date: 2010-08-31

Vivaglobin
    Dosage: 9.6 g 2x/week, stop day may 2011 subcutaneous, (9.6 g 2x/week, stop day may 2011 subcutaneous
    Indication: Immunodeficiency Common Variable
    Start date: 2010-08-31

Vivaglobin
    Dosage: 9.6 g 2x/week, stop day may 2011 subcutaneous, (9.6 g 2x/week, stop day may 2011 subcutaneous
    Indication: Hypogammaglobulinaemia
    Start date: 2011-03-29

Vivaglobin
    Dosage: 9.6 g 2x/week, stop day may 2011 subcutaneous, (9.6 g 2x/week, stop day may 2011 subcutaneous
    Indication: Immunodeficiency Common Variable
    Start date: 2011-03-29

Vivaglobin
    Dosage: 9.6 g 2x/week, stop day may 2011 subcutaneous, (9.6 g 2x/week, stop day may 2011 subcutaneous
    Indication: Hypogammaglobulinaemia
    Start date: 2009-11-17

Vivaglobin
    Dosage: 9.6 g 2x/week, stop day may 2011 subcutaneous, (9.6 g 2x/week, stop day may 2011 subcutaneous
    Indication: Immunodeficiency Common Variable
    Start date: 2009-11-17

Vivaglobin
    Dosage: 9.6 g 2x/week, stop day may 2011 subcutaneous, (9.6 g 2x/week, stop day may 2011 subcutaneous
    Indication: Hypogammaglobulinaemia
    Start date: 2009-12-15

Vivaglobin
    Dosage: 9.6 g 2x/week, stop day may 2011 subcutaneous, (9.6 g 2x/week, stop day may 2011 subcutaneous
    Indication: Immunodeficiency Common Variable
    Start date: 2009-12-15

Vivaglobin
    Dosage: 9.6 g 2x/week, stop day may 2011 subcutaneous, (9.6 g 2x/week, stop day may 2011 subcutaneous
    Indication: Hypogammaglobulinaemia
    Start date: 2010-12-21

Vivaglobin
    Dosage: 9.6 g 2x/week, stop day may 2011 subcutaneous, (9.6 g 2x/week, stop day may 2011 subcutaneous
    Indication: Immunodeficiency Common Variable
    Start date: 2010-12-21

Vivaglobin
    Dosage: 9.6 g 2x/week, stop day may 2011 subcutaneous, (9.6 g 2x/week, stop day may 2011 subcutaneous
    Indication: Hypogammaglobulinaemia
    Start date: 2010-03-16

Vivaglobin
    Dosage: 9.6 g 2x/week, stop day may 2011 subcutaneous, (9.6 g 2x/week, stop day may 2011 subcutaneous
    Indication: Immunodeficiency Common Variable
    Start date: 2010-03-16

Vivaglobin
    Dosage: 9.6 g 2x/week, stop day may 2011 subcutaneous, (9.6 g 2x/week, stop day may 2011 subcutaneous
    Indication: Hypogammaglobulinaemia
    Start date: 2011-04-27

Vivaglobin
    Dosage: 9.6 g 2x/week, stop day may 2011 subcutaneous, (9.6 g 2x/week, stop day may 2011 subcutaneous
    Indication: Immunodeficiency Common Variable
    Start date: 2011-04-27

Vivaglobin
    Dosage: 9.6 g 2x/week, stop day may 2011 subcutaneous, (9.6 g 2x/week, stop day may 2011 subcutaneous
    Indication: Hypogammaglobulinaemia
    Start date: 2010-08-03

Vivaglobin
    Dosage: 9.6 g 2x/week, stop day may 2011 subcutaneous, (9.6 g 2x/week, stop day may 2011 subcutaneous
    Indication: Immunodeficiency Common Variable
    Start date: 2010-08-03

Vivaglobin
    Dosage: 9.6 g 2x/week, stop day may 2011 subcutaneous, (9.6 g 2x/week, stop day may 2011 subcutaneous
    Indication: Hypogammaglobulinaemia
    Start date: 2010-10-26

Vivaglobin
    Dosage: 9.6 g 2x/week, stop day may 2011 subcutaneous, (9.6 g 2x/week, stop day may 2011 subcutaneous
    Indication: Immunodeficiency Common Variable
    Start date: 2010-10-26

Vivaglobin
    Dosage: 9.6 g 2x/week, stop day may 2011 subcutaneous, (9.6 g 2x/week, stop day may 2011 subcutaneous
    Indication: Hypogammaglobulinaemia
    Start date: 2011-01-06

Vivaglobin
    Dosage: 9.6 g 2x/week, stop day may 2011 subcutaneous, (9.6 g 2x/week, stop day may 2011 subcutaneous
    Indication: Immunodeficiency Common Variable
    Start date: 2011-01-06

Vivaglobin
    Dosage: 9.6 g 2x/week, stop day may 2011 subcutaneous, (9.6 g 2x/week, stop day may 2011 subcutaneous
    Indication: Hypogammaglobulinaemia
    Start date: 2011-02-22

Vivaglobin
    Dosage: 9.6 g 2x/week, stop day may 2011 subcutaneous, (9.6 g 2x/week, stop day may 2011 subcutaneous
    Indication: Immunodeficiency Common Variable
    Start date: 2011-02-22

Vivaglobin
    Dosage: 9.6 g 2x/week, stop day may 2011 subcutaneous, (9.6 g 2x/week, stop day may 2011 subcutaneous
    Indication: Hypogammaglobulinaemia
    Start date: 2010-02-16

Vivaglobin
    Dosage: 9.6 g 2x/week, stop day may 2011 subcutaneous, (9.6 g 2x/week, stop day may 2011 subcutaneous
    Indication: Immunodeficiency Common Variable
    Start date: 2010-02-16

Vivaglobin
    Dosage: 9.6 g 2x/week, stop day may 2011 subcutaneous, (9.6 g 2x/week, stop day may 2011 subcutaneous
    Indication: Hypogammaglobulinaemia
    Start date: 2010-05-11

Vivaglobin
    Dosage: 9.6 g 2x/week, stop day may 2011 subcutaneous, (9.6 g 2x/week, stop day may 2011 subcutaneous
    Indication: Immunodeficiency Common Variable
    Start date: 2010-05-11

Vivaglobin
    Dosage: 9.6 g 2x/week, stop day may 2011 subcutaneous, (9.6 g 2x/week, stop day may 2011 subcutaneous
    Indication: Hypogammaglobulinaemia
    Start date: 2010-07-06

Vivaglobin
    Dosage: 9.6 g 2x/week, stop day may 2011 subcutaneous, (9.6 g 2x/week, stop day may 2011 subcutaneous
    Indication: Immunodeficiency Common Variable
    Start date: 2010-07-06

Vivaglobin
    Dosage: 9.6 g 2x/week, stop day may 2011 subcutaneous, (9.6 g 2x/week, stop day may 2011 subcutaneous
    Indication: Hypogammaglobulinaemia
    Start date: 2010-11-22

Vivaglobin
    Dosage: 9.6 g 2x/week, stop day may 2011 subcutaneous, (9.6 g 2x/week, stop day may 2011 subcutaneous
    Indication: Immunodeficiency Common Variable
    Start date: 2010-11-22

Vivaglobin
    Dosage: 9.6 g 2x/week, stop day may 2011 subcutaneous, (9.6 g 2x/week, stop day may 2011 subcutaneous
    Indication: Hypogammaglobulinaemia
    Start date: 2011-01-26

Vivaglobin
    Dosage: 9.6 g 2x/week, stop day may 2011 subcutaneous, (9.6 g 2x/week, stop day may 2011 subcutaneous
    Indication: Immunodeficiency Common Variable
    Start date: 2011-01-26

Vivaglobin

Vivaglobin

Vivaglobin

Vivaglobin

Vivaglobin

Vivaglobin

Vivaglobin

Vivaglobin



Possible Vivaglobin side effects in female

Reported by a pharmacist from United States on 2012-04-23

Patient: female, weighing 61.2 kg (134.7 pounds)

Reactions: Herpes Simplex Serology Positive, Transmission of AN Infectious Agent VIA A Medicinal Product

Drug(s) suspected as cause:
Vivaglobin

Vivaglobin

Vivaglobin

Vivaglobin

Vivaglobin

Vivaglobin

Vivaglobin

Vivaglobin

Vivaglobin

Vivaglobin

Vivaglobin

Vivaglobin

Vivaglobin

Vivaglobin

Vivaglobin

Vivaglobin

Vivaglobin
    Dosage: (9.6 g 1x/week subcutaneous)
    Indication: Hypogammaglobulinaemia
    Start date: 2009-11-17
    End date: 2011-05-01

Vivaglobin
    Dosage: (9.6 g 1x/week subcutaneous)
    Indication: Immunodeficiency Common Variable
    Start date: 2009-11-17
    End date: 2011-05-01

Vivaglobin
    Dosage: (9.6 g 1x/week subcutaneous)
    Indication: Hypogammaglobulinaemia
    Start date: 2010-10-26

Vivaglobin
    Dosage: (9.6 g 1x/week subcutaneous)
    Indication: Immunodeficiency Common Variable
    Start date: 2010-10-26

Vivaglobin
    Dosage: (9.6 g 1x/week subcutaneous)
    Indication: Hypogammaglobulinaemia
    Start date: 2010-02-16

Vivaglobin
    Dosage: (9.6 g 1x/week subcutaneous)
    Indication: Immunodeficiency Common Variable
    Start date: 2010-02-16

Vivaglobin
    Dosage: (9.6 g 1x/week subcutaneous)
    Indication: Hypogammaglobulinaemia
    Start date: 2011-01-06

Vivaglobin
    Dosage: (9.6 g 1x/week subcutaneous)
    Indication: Immunodeficiency Common Variable
    Start date: 2011-01-06

Vivaglobin
    Dosage: (9.6 g 1x/week subcutaneous)
    Indication: Hypogammaglobulinaemia
    Start date: 2010-03-16

Vivaglobin
    Dosage: (9.6 g 1x/week subcutaneous)
    Indication: Immunodeficiency Common Variable
    Start date: 2010-03-16

Vivaglobin
    Dosage: (9.6 g 1x/week subcutaneous)
    Indication: Hypogammaglobulinaemia
    Start date: 2010-05-11

Vivaglobin
    Dosage: (9.6 g 1x/week subcutaneous)
    Indication: Immunodeficiency Common Variable
    Start date: 2010-05-11

Vivaglobin
    Dosage: (9.6 g 1x/week subcutaneous)
    Indication: Hypogammaglobulinaemia
    Start date: 2010-08-31

Vivaglobin
    Dosage: (9.6 g 1x/week subcutaneous)
    Indication: Immunodeficiency Common Variable
    Start date: 2010-08-31

Vivaglobin
    Dosage: (9.6 g 1x/week subcutaneous)
    Indication: Hypogammaglobulinaemia
    Start date: 2011-04-27

Vivaglobin
    Dosage: (9.6 g 1x/week subcutaneous)
    Indication: Immunodeficiency Common Variable
    Start date: 2011-04-27

Vivaglobin
    Dosage: (9.6 g 1x/week subcutaneous)
    Indication: Hypogammaglobulinaemia
    Start date: 2009-12-15

Vivaglobin
    Dosage: (9.6 g 1x/week subcutaneous)
    Indication: Immunodeficiency Common Variable
    Start date: 2009-12-15

Vivaglobin
    Dosage: (9.6 g 1x/week subcutaneous)
    Indication: Hypogammaglobulinaemia
    Start date: 2010-06-07

Vivaglobin
    Dosage: (9.6 g 1x/week subcutaneous)
    Indication: Immunodeficiency Common Variable
    Start date: 2010-06-07

Vivaglobin
    Dosage: (9.6 g 1x/week subcutaneous)
    Indication: Hypogammaglobulinaemia
    Start date: 2010-11-22

Vivaglobin
    Dosage: (9.6 g 1x/week subcutaneous)
    Indication: Immunodeficiency Common Variable
    Start date: 2010-11-22

Vivaglobin
    Dosage: (9.6 g 1x/week subcutaneous)
    Indication: Hypogammaglobulinaemia
    Start date: 2011-03-29

Vivaglobin
    Dosage: (9.6 g 1x/week subcutaneous)
    Indication: Immunodeficiency Common Variable
    Start date: 2011-03-29

Vivaglobin
    Dosage: (9.6 g 1x/week subcutaneous)
    Indication: Hypogammaglobulinaemia
    Start date: 2010-01-18

Vivaglobin
    Dosage: (9.6 g 1x/week subcutaneous)
    Indication: Immunodeficiency Common Variable
    Start date: 2010-01-18

Vivaglobin
    Dosage: (9.6 g 1x/week subcutaneous)
    Indication: Hypogammaglobulinaemia
    Start date: 2010-07-06

Vivaglobin
    Dosage: (9.6 g 1x/week subcutaneous)
    Indication: Immunodeficiency Common Variable
    Start date: 2010-07-06

Vivaglobin
    Dosage: (9.6 g 1x/week subcutaneous)
    Indication: Hypogammaglobulinaemia
    Start date: 2011-01-26

Vivaglobin
    Dosage: (9.6 g 1x/week subcutaneous)
    Indication: Immunodeficiency Common Variable
    Start date: 2011-01-26

Vivaglobin
    Dosage: (9.6 g 1x/week subcutaneous)
    Indication: Hypogammaglobulinaemia
    Start date: 2011-02-22

Vivaglobin
    Dosage: (9.6 g 1x/week subcutaneous)
    Indication: Immunodeficiency Common Variable
    Start date: 2011-02-22

Vivaglobin
    Dosage: (9.6 g 1x/week subcutaneous)
    Indication: Hypogammaglobulinaemia
    Start date: 2010-09-28

Vivaglobin
    Dosage: (9.6 g 1x/week subcutaneous)
    Indication: Immunodeficiency Common Variable
    Start date: 2010-09-28

Vivaglobin
    Dosage: (9.6 g 1x/week subcutaneous)
    Indication: Hypogammaglobulinaemia
    Start date: 2010-12-21

Vivaglobin
    Dosage: (9.6 g 1x/week subcutaneous)
    Indication: Immunodeficiency Common Variable
    Start date: 2010-12-21

Vivaglobin
    Dosage: (9.6 g 1x/week subcutaneous)
    Indication: Hypogammaglobulinaemia
    Start date: 2009-11-17

Vivaglobin
    Dosage: (9.6 g 1x/week subcutaneous)
    Indication: Immunodeficiency Common Variable
    Start date: 2009-11-17

Vivaglobin
    Dosage: (9.6 g 1x/week subcutaneous)
    Indication: Hypogammaglobulinaemia
    Start date: 2010-08-03

Vivaglobin
    Dosage: (9.6 g 1x/week subcutaneous)
    Indication: Immunodeficiency Common Variable
    Start date: 2010-08-03

Vivaglobin

Vivaglobin

Vivaglobin

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017